Abstract
Recent studies in our laboratory have identified novel molecular diagnostic and prognostic markers based on analyses in large cohorts of melanoma patients. These markers were initially derived from gene expression profiling analyses of distinct stages of melanoma progression. Immunohistochemical analyses confirmed the differential expression of these markers, and immunohistochemistry-based multimarker assays were developed to assess melanoma diagnosis and prognosis at the molecular level. In this chapter we review the development of these assays and the methodologies used to assess marker expression in both nevi and primary melanomas.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Ming ME (2000) The histopathologic misdiagnosis of melanoma: sources and consequences of “false positives” and “false negatives”. J Am Acad Dermatol 43:704–706
Piepkorn MW et al (1994) A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol 30:707–714
Farmer ER, Gonin R, Hanna MP (1996) Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 27:528–531
Corona R et al (1996) Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 14:1218–1223
Barnhill RL et al (1999) Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 30:1523–1526
Brochez L et al (2002) Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 196: 459–466
Troxel DB (2003) Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study. Am J Surg Pathol 27: 1278–1283
Wettengel GV, Draeger J, Kiesewetter F, Schell H, Neubauer S, Gebhart E (1999) Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization. Int J Oncol 14:1177–1183
Bastian BC, Wesselmann U, Pinkel D, Leboit PE (1999) Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 11:1065–1069
Busam KJ et al (1998) Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 22:976–982
King R, Weilbaecher KN, McGill G, Cooley Mihm M, Fisher DE (1999) Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 155:731–738
Fullen DR, Reed JA, Finnerty B, McNutt NS (2001) S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi. J Cutan Pathol 28: 393–399
King R, Googe PB, Weilbaecher KN, Mihm MC Jr, Fisher DE (2001) Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol 25:51–57
Kucher C et al (2004) Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol 26: 452–457
Haqq C et al (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A 102:6092–6097
Kashani-Sabet M et al (2009) A multi-marker assay to distinguish benign nevi from malignant melanomas. Proc Natl Acad Sci U S A 106: 6268–6272
Gogas H et al (2009) Biomarkers in melanoma. Ann Oncol 20(Suppl 6):vi 8–13
Kashani-Sabet M et al (2009) A multi-marker prognostic assay for melanoma. Clin Cancer Res 15:6987–6992
Rangel J et al (2006) Prognostic significance of NCOA3 overexpression in primary cutaneous melanoma. J Clin Oncol 24:4565–4569
Rangel J et al (2008) Osteopontin as a molecular prognostic marker for melanoma. Cancer 112:144–150
Rangel J et al (2008) Novel role for RGS1 in melanoma progression. Am J Surg Pathol 32: 1207–1212
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Nosrati, M., Kashani-Sabet, M. (2014). Immunohistochemical Diagnostic and Prognostic Markers for Melanoma. In: Thurin, M., Marincola, F. (eds) Molecular Diagnostics for Melanoma. Methods in Molecular Biology, vol 1102. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-727-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-62703-727-3_14
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-726-6
Online ISBN: 978-1-62703-727-3
eBook Packages: Springer Protocols